Boyer David W. sold NBIX
October 3, 2024 · Form 4 insider transaction
Boyer David W. sold 1,295 shares of Neurocrine Biosciences, Inc. at $113.66 per share, a transaction worth $147.2K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,295
Price
$113.66
Total value
$147.2K
InsiderBoyer David W.
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateOctober 3, 2024
Filing dateOctober 7, 2024
Shares owned after377
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2024. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.